Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction.
Spiroski AM, McCracken IR, Thomson A, Magalhaes-Pinto M, Lalwani MK, Newton KJ, Miller E, Bénézech C, Hadoke P, Brittan M, Mountford JC, Beqqali A, Gray GA, Baker AH.
Spiroski AM, et al. Among authors: benezech c.
Front Cardiovasc Med. 2022 Oct 10;9:953211. doi: 10.3389/fcvm.2022.953211. eCollection 2022.
Front Cardiovasc Med. 2022.
PMID: 36299872
Free PMC article.